Cipla receives Form 483 observation from USFDA | Republic World
Advertisement

Published 16:54 IST, May 8th 2024

Cipla receives Form 483 observation from USFDA for Maharashtra facility

The Form 483, issued by the US Food and Drug Administration (USFDA), signifies observations made by inspectors at the conclusion of an inspection.

Reported by: Business Desk
Follow: Google News Icon
  • share
Cipla Q3 results
Cipla's revenue from operations during Q3 reached Rs 6,603.81 crore. | Image: Freepik
  • Listen to this article
  • 1 min read

16:54 IST, May 8th 2024

Advertisement